The purpose of the CamNTF is to promote interactions between scientists from academia and industry to accelerate opportunities for biotechnology research and development. The event is open to all researchers interested in new therapeutics in the Cambridge area. 

Agenda
16:30 – 17:00 Registration
17:00 – 18:05 Presentations:
Tim Coorens, Group Leader, EMBL-EBI
New technologies to research somatic evolution and the origins of disease
Polina Rusina, Drug Discovery Scientist, Open Targets (EMBL-EBI)
Drowning in Targets, Guided by Evidence: Systematic target prioritisation to inform drug discovery decision making
Carl Anderson, Head of Human Genetics and Senior Group Leader, Wellcome Sanger Institute
Using genetics and single-cell RNA-seq to nominate candidate drug targets for inflammatory bowel disease
18:05 – 19:00 Buffet and networking